Once-daily oral omadacycline versus twice-daily oral linezolid for acute bacterial skin and skin structure infections (OASIS-2): a phase 3, double-blind, multicentre, randomised, controlled, non-inferiority trial
| Autor: | O'Riordan, William, Cardenas, Carrie, Shin, Elliot, Sirbu, Alissa, Garrity-Ryan, Lynne *, Das, Anita F, Eckburg, Paul B, Manley, Amy, Steenbergen, Judith N, Tzanis, Evan, McGovern, Paul C, Loh, Evan |
|---|---|
| Zdroj: | In The Lancet Infectious Diseases October 2019 19(10):1080-1090 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|